Minerva Neurosciences to Present at 23rd Annual NewsMakers in the Biotech Industry Conference on September 9, 2016
(Thomson Reuters ONE) -
WALTHAM, Mass., Sept. 02, 2016 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc.
(NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the
development of innovative therapies to treat central nervous system (CNS)
disorders, today announced that it will present at the 23rd Annual NewsMakers in
the Biotech Industry conference in New York on Friday, September 9, 2016 at
1:30 p.m. eastern time.
The presentation will be webcast and accessible through the investor relations
section of the Company's web site, http://ir.minervaneurosciences.com.
About Minerva Neurosciences
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company
focused on the development and commercialization of a portfolio of products to
treat CNS diseases. Minerva's proprietary compounds include: MIN-101, which has
completed Phase IIb development for schizophrenia; MIN-202 (JNJ-42847922), which
has completed Phase IIa and Phase Ib clinical trials in insomnia and major
depressive order (MDD), respectively; MIN-117, which has completed Phase IIa
development for MDD; and MIN-301, in pre-clinical development for Parkinson's
disease. Minerva's common stock is listed on the NASDAQ Global Market under the
symbol "NERV." For more information, please visitwww.minervaneurosciences.com.
Contact:
William B. Boni
VP, Investor Relations/
Corp. Communications
Minerva Neurosciences, Inc.
(617) 600-7376
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Minerva Neurosciences, Inc. via GlobeNewswire
Datum: 02.09.2016 - 14:30 Uhr
Sprache: Deutsch
News-ID 492480
Anzahl Zeichen: 2017
contact information:
Town:
Waltham
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 250 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Minerva Neurosciences to Present at 23rd Annual NewsMakers in the Biotech Industry Conference on September 9, 2016"
steht unter der journalistisch-redaktionellen Verantwortung von
Minerva Neurosciences, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
